Q-omics provides the consensus-scored RBPJP5 profile across patient tissues and cancer cell-line models. RBPJP5 expression is associated with patient survival in 9 of 34 cancer types, with the highest sampling consensus in MESO. Additionally, RBPJP5 RNA expression shows 3,289 significant protein co-abundance associations, with the highest sampling consensus in OV. Together, these results highlight MESO, and OV as cancer lineages where RBPJP5 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.